Abiraterone in the treatment of metastatic castration-resistant prostate cancer
about
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Beyond T and DHT - novel steroid derivatives capable of wild type androgen receptor activationMolecular pathways and targets in prostate cancerMinireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.Study of cases of abiraterone discontinuation due to toxicity in pre-chemotherapy after 1 year's experience.Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone.[Antihormonal therapy in prostate cancer : Side effects].Resistance to Hormonal Therapy in Prostate Cancer.
P2860
Q26774221-1A9A17BC-18BE-4A40-AFE7-E33AA26DB23CQ27007208-AEBF697E-760C-4082-9573-BCA95AF04363Q34365632-6DFA0C0C-9327-4846-A3B0-1ED3823935B2Q38242231-9BF85EB9-E439-4ECD-816B-F8D45D084E89Q38661520-F90B58C7-EA23-4166-81B3-8B839A01582BQ38983833-19EBC58D-A63E-4F28-B148-A0D459143565Q42019892-2F61B218-316A-404A-916C-A0623CD35AC3Q42321600-D31B0B91-AE91-4B33-8349-A40B1A4EC534Q47699658-BB47E476-5A99-4EA4-9827-7C416E6D68A2Q48744603-21C17F2C-4874-44A1-BD17-7F113CCAD1B2Q53393993-F4C77E2D-3838-41C1-9A4B-A5844F2B225C
P2860
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@ast
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@en
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@nl
type
label
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@ast
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@en
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@nl
prefLabel
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@ast
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@en
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@nl
P2860
P356
P1476
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
@en
P2093
Elahe Mostaghel
P2860
P356
10.2147/CMAR.S39318
P407
P577
2014-01-01T00:00:00Z